New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For NRG;GEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2016
10:05 EDTNRGOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Equity (AEL) initiated with an Outperform at RBC Capital... Calpine (CPN) initiated with a Buy at Guggenheim... Diamondback Energy (FANG) initiated with an Outperform at BMO Capital... Dynegy (DYN) initiated with a Neutral at Guggenheim... ICF International (ICFI) initiated with a Market Perform at Barrington... Juno Therapeutics (JUNO) initiated with a Buy at SunTrust... Kite Pharma (KITE) initiated with a Buy at SunTrust... Match Group (MTCH) initiated with a Neutral at Susquehanna... Medifast (MED) initiated with a Hold at Wunderlich... NRG Energy (NRG) initiated with a Buy at Guggenheim... NRG Yield (NYLD) initiated with a Neutral at Guggenheim... Nutrisystem (NTRI) initiated with a Buy at Wunderlich... Parsley Energy (PE) initiated with an Outperform at BMO Capital... Precision Drilling (PDS) initiated with a Hold at Canaccord... RSP Permian (RSPP) initiated with an Outperform at BMO Capital... Taylor Morrison (TMHC) initiated with a Neutral at Citi... Tortoise North American Energy (TYN) initiated with a Neutral at Guggenheim... WisdomTree (WETF) initiated with a Neutral at Northcoast.
January 28, 2016
17:07 EDTNRGNRG Energy initiated with a Buy at Guggenheim
Subscribe for More Information
January 26, 2016
08:34 EDTGENGenesis Healthcare price target lowered to $3 from $9 at Stephens
Stephens analyst Dana Hambly noted that Genesis Healthcare's negative earnings preannouncement was its second such bad surprise in only a year of being public, which is damaging to its credibility. Citing the worse than expected earnings and 2016 outlook, Hambly lowered his price target on the stock to $3 from $9. However, he keeps an Overweight rating on shares, as he estimates FCF yields over 20% in 2016 and still thinks Genesis will be able to make significant market share gains over time.
January 25, 2016
15:25 EDTGENGenesis Healthcare downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
15:03 EDTNRGPJM-linked energy generators crash after Supreme Court upholds 'demand response'
Shares of Dynegy (DYN) and select peers are trading lower after the Supreme Court ruled in favor of the Federal Energy Regulatory Commission and its so-called demand response, an industry practice that seeks to encourage lower energy usage. The rule, which pays customers for not using power, effectively boosts supply and increases pressure on prices in the PJM power grid, the nation's biggest merchant power market. Dynegy, Talen (TLN), Exelon (EXC) and FirstEnergy (FE) are the largest merchant generators in PJM, according to Bloomberg data. PRICE ACTION: Dynegy has fallen roughly 11.2% to $9.92. Exelon, NRG Energy (NRG), Talen and Calpine (CPN) have slipped 2.8%, 7.8%, 5.2%, and 7.7%, respectively, while energy savings firm EnerNOC (ENOC) jumped nearly 78% in the wake of the ruling.
08:38 EDTGENGenesis Healthcare sees FY16 adjusted EPS 19c-29c, consensus 44c
Subscribe for More Information
08:36 EDTGENGenesis Healthcare adjusts Q4 guidance due to impact of three items
Preliminary results for the fourth quarter of 2015 were primarily impacted by three items: Approximately $15 million of higher than expected self-insurance reserve adjustments principally as a consequence of recently concluded actuarially estimated professional liability exposure largely related to adverse claims development on open policy periods; Approximately $6 million of higher bad debt expense, principally associated with the former Skilled Healthcare facilities, which coincides with system conversions and operational integration activities that began in the summer of 2015; and approximately $5 million from lower than expected organic revenue growth in both the inpatient and rehabilitation therapy business segments.
08:36 EDTGENGenesis Healthcare sees FY15 adjusted EPS 21c-23c, consensus 36c
Sees FY15 net revenue $5.63B-$5.66B, consensus $5.64B. Sees FY15 adjusted EBITDAR $730M-$736M. Sees FY15 adjusted EBITDA $246M-$252M.
08:35 EDTGENGenesis Healthcare sees Q4 adjusted EPS (6c)-(4c), consensus 9c
Sees Q4 revenue $1.41B-$1.44B, consensus $1.42B. Sees Q4 adjusted EBITDAR $158M-$164M. Sees Q4 adjusted EBITDA $36M-$42M.
08:33 EDTGENGenesis Healthcare expects to deliver 6% YoY EBITDAR growth
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use